PSY19 THE COST-EFFECTIVENESS OF BORTEZOMIB PLUS MELPHALAN AND PREDNISONE VERSUS LENALIDOMIDE PLUS MELPHALAN AND PREDNISONE WITH CONTINUOUS LENALIDOMIDE MAINTENANCE TREATMENT FOR THE INITIAL TREATMENT OF MULTIPLE MYELOMA IN THE UNITED STATES

✍ Scribed by S.T. Wang; H. Huang; A. Ba-mancini; H. Shi; K. Chen; C. Korves; R. Dhawan; A. Cakana; H. van de Velde; M.S. Duh

• Book ID: 119309133
• Publisher: John Wiley and Sons
• Year: 2011
• Tongue: English
• Weight: 58 KB
• Volume: 14
• Category: Article
• ISSN: 1098-3015
• DOI: 10.1016/j.jval.2011.02.352